U.S. Markets closed

Opexa Therapeutics, Inc. (OPXA)

NASDAQ Capital Market - NASDAQ Capital Market Real Time Price. Currency in USD
Add to watchlist
0.95+0.16 (+20.25%)
At close: 4:00PM EDT

0.92 -0.03 (-3.16%)
After hours: 5:28PM EDT

People also watch
CYTXCURPSTIOSIRCYCC
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue2,905.1652,556.3291,271.895
Cost of Revenue---
Gross Profit2,905.1652,556.3291,271.895
Operating Expenses
Research Development6,497.53110,039.49612,118.629
Selling General and Administrative3,122.3374,258.1473,833.37
Non Recurring1,036.4671,036.4671,036.467
Others238.127351.403387.779
Total Operating Expenses10,894.462--
Operating Income or Loss-7,991.617-12,093.884-15,067.883
Income from Continuing Operations
Total Other Income/Expenses Net9.18373.43915.62
Earnings Before Interest and Taxes-7,982.434-12,020.445-15,052.263
Interest Expense---
Income Before Tax-7,982.434-12,020.445-15,052.263
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-7,982.434-12,020.445-15,052.263
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-7,980.114-12,019.278-15,052.263
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-7,980.114-12,019.278-15,052.263